Evidence map›Paper›PMID 25233006›Full record

ArticlePLoS pathogens2014

Molecular insights into the evolutionary pathway of Vibrio cholerae O1 atypical El Tor variants.

Eun Jin Kim, Dokyung Lee, Se Hoon Moon, Chan Hee Lee, Sang Jun Kim, Jae Hyun Lee, Jae Ouk Kim, Manki Song, Bhabatosh Das, John D Clemens and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Atypical El TorMicrobiology spectrum · 2026
    Article
  2. Strain-dependentFrontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in medicine · 2023
    Review
  10. Outbreak of cholera in a remote village in western India.The Indian journal of medical research · 2022
    Article
  11. Article
  12. Article
  13. VicPred: AFrontiers in microbiology · 2021
    Article
  14. Article
  15. Cholera Toxin Production inFrontiers in microbiology · 2020
    Article
  16. Article
  17. The TLCΦ satellite phage harbors a Xer recombination activation factor.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Utilization of Small RNA Genes to DistinguishThe American journal of tropical medicine and hygiene · 2019
    Article
  19. Surveillance and Genomics of ToxigenicFrontiers in microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Eun Jin KimDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea; Institute of Pharmacological Research, Hanyang University, Ansan, Korea.
Dokyung LeeDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea; Institute of Pharmacological Research, Hanyang University, Ansan, Korea.
Se Hoon MoonDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea; Institute of Pharmacological Research, Hanyang University, Ansan, Korea.
Chan Hee LeeDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea; Institute of Pharmacological Research, Hanyang University, Ansan, Korea.
Sang Jun KimDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea.
Jae Hyun LeeDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea.
Jae Ouk KimLaboratory Science Division, International Vaccine Institute, Seoul, Korea.
Manki SongLaboratory Science Division, International Vaccine Institute, Seoul, Korea.
Bhabatosh DasTranslational Health Science and Technology Institute, Gurgaon, Haryana, India.
John D ClemensInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; UCLA Fielding School of Public Health, Los Angeles, California, United States of America.
Jean William PapeDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America; Les Centres GHESKIO, Port-au-Prince, Haïti.
G Balakrish NairTranslational Health Science and Technology Institute, Gurgaon, Haryana, India.
Dong Wook KimDepartment of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Korea; Institute of Pharmacological Research, Hanyang University, Ansan, Korea.
Hanyang University · KRInternational Vaccine Institute · KRTranslational Health Science and Technology Institute · INCornell University · USInternational Centre for Diarrhoeal Disease Research · BD

Funding

GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
GHESKIO HIV Clinical Trial UnitU01AI069421 · NIAID · GHESKIO CENTER · PI PAPE, JEAN WILLIAM · 2007 to 2011
$8.4M
NIAID NIH HHS UM1 AI069421
6 · The paper itself

Abstract

Pandemic V. cholerae strains in the O1 serogroup have 2 biotypes: classical and El Tor. The classical biotype strains of the sixth pandemic, which encode the classical type cholera toxin (CT), have been replaced by El Tor biotype strains of the seventh pandemic. The prototype El Tor strains that produce biotype-specific cholera toxin are being replaced by atypical El Tor variants that harbor classical cholera toxin. Atypical El Tor strains are categorized into 2 groups, Wave 2 and Wave 3 strains, based on genomic variations and the CTX phage that they harbor. Whole-genome analysis of V. cholerae strains in the seventh cholera pandemic has demonstrated gradual changes in the genome of prototype and atypical El Tor strains, indicating that atypical strains arose from the prototype strains by replacing the CTX phages. We examined the molecular mechanisms that effected the emergence of El Tor strains with classical cholera toxin-carrying phage. We isolated an intermediary V. cholerae strain that carried two different CTX phages that encode El Tor and classical cholera toxin, respectively. We show here that the intermediary strain can be converted into various Wave 2 strains and can act as the source of the novel mosaic CTX phages. These results imply that the Wave 2 and Wave 3 strains may have been generated from such intermediary strains in nature. Prototype El Tor strains can become Wave 3 strains by excision of CTX-1 and re-equipping with the new CTX phages. Our data suggest that inter-chromosomal recombination between 2 types of CTX phages is possible when a host bacterial cell is infected by multiple CTX phages. Our study also provides molecular insights into population changes in V. cholerae in the absence of significant changes to the genome but by replacement of the CTX prophage that they harbor.

Indexed as

Biological EvolutionBacterial Typing TechniquesBacteriophagesCholeraCholera ToxinGenetic VariationGenome, ViralMolecular Sequence DataProphagesVibrio cholerae O1Cholera Toxin

Identifiers

PMID25233006
PMCPMC4169478
OpenAlexW2066452573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.